Skip to main content
OpenTrials

Clinical trial condition

Chickenpox

Explore clinical trials studying Chickenpox. Study availability and eligibility vary by location and protocol.

19 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Chickenpox trial results

Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Huntington Park, California, United States
  • GSK Investigational Site Sherman Oaks, California, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT06806137

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Salvaleón de Higüey, La Altagracia Province, Dominican Republic
  • GSK Investigational Site Constanza, Dominican Republic
  • GSK Investigational Site Santo Domingo Oeste, Dominican Republic
  • GSK Investigational Site San Pedro Sula, Honduras
View Trial Details
Completed

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

NCT05084508

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Bryant, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bellflower, California, United States
View all 51 locations
View Trial Details
Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

NCT00001125

Conditions
Blood-Borne Infections, Chickenpox, Communicable Diseases, +15 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance, California, United States
View all 22 locations
View Trial Details
Completed

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

NCT02570126

Conditions
Chicken-pox Illness (Varicella Virus Disease), Chickenpox, DNA Virus Infections, +4 more
Locations
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tartu, Estonia
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
View all 23 locations
View Trial Details

Related conditions